| Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd Z Wang, CD Monteiro, KM Jagodnik, NF Fernandez, GW Gundersen, ... Nature communications 7 (1), 12846, 2016 | 251 | 2016 |
| Interethnic variation of CYP2C19 alleles,‘predicted’phenotypes and ‘measured’metabolic phenotypes across world populations I Fricke-Galindo, C Céspedes-Garro, F Rodrigues-Soares, MEG Naranjo, ... The pharmacogenomics journal 16, 113-123, 2016 | 163 | 2016 |
| Use of toxicity assays for enantiomeric discrimination of pharmaceutical substances F De Andrés, G Castañeda, Á Ríos Chirality: The Pharmacological, Biological, and Chemical Consequences of …, 2009 | 88 | 2009 |
| Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes C Céspedes-Garro, I Fricke-Galindo, MEG Naranjo, F Rodrigues-Soares, ... Expert opinion on drug metabolism & toxicology 11 (12), 1893-1905, 2015 | 67 | 2015 |
| Determination of zearalenone and its metabolites in urine samples by liquid chromatography with electrochemical detection using a carbon nanotube-modified electrode F de Andrés, M Zougagh, G Castañeda, A Ríos Journal of Chromatography A 1212 (1-2), 54-60, 2008 | 62 | 2008 |
| VEGF-related polymorphisms identified by GWAS and risk for major depression T Xie, MG Stathopoulou, F De Andrés, G Siest, H Murray, M Martin, ... Translational psychiatry 7 (3), e1055-e1055, 2017 | 50 | 2017 |
| Lasmiditan for the treatment of migraine. M Capi, F de Andrés, L Lionetto, G Gentile, F Cipolla, M Borro, ... Expert Opinion on Investigational Drugs 26 (2), 227-234, 2017 | 44 | 2017 |
| To genotype or phenotype for personalized medicine? CYP450 drug metabolizing enzyme genotype–phenotype concordance and discordance in the Ecuadorian population F De Andrés, S Terán, F Hernández, E Terán, A LLerena Omics: a journal of integrative biology 20 (12), 699-710, 2016 | 44 | 2016 |
| A rapid and simple LC–MS/MS method for the simultaneous evaluation of CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 hydroxylation capacity F De Andrés, M Sosa-Macías, A LLerena Bioanalysis 6 (5), 683-696, 2014 | 43 | 2014 |
| Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF … MEG Naranjo, F Rodrigues-Soares, EM Penas-Lledo, E Tarazona-Santos, ... Omics: a journal of integrative biology 22 (9), 575-588, 2018 | 40 | 2018 |
| Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response M Capi, M Curto, L Lionetto, F de Andrés, G Gentile, A Negro, P Martelletti Therapeutic Advances in Neurological Disorders 9 (4), 414-423, 2016 | 40 | 2016 |
| Bioanalytical applications using supercritical fluid techniques A Ríos, M Zougagh, F de Andrés Bioanalysis 2, 9-25, 2010 | 37 | 2010 |
| Effects of Khat (Catha edulis) use on catalytic activities of major drug-metabolizing cytochrome P450 enzymes and implication of pharmacogenetic variations W Bedada, F de Andrés, E Engidawork, J Hussein, A LLerena, E Aklillu Scientific reports 8 (1), 12726, 2018 | 35 | 2018 |
| Simultaneous determination of cytochrome P450 oxidation capacity in humans: a review on the phenotyping cocktail approach F de Andrés, A LLerena Current Pharmaceutical Biotechnology 17 (13), 1159-1180, 2016 | 34 | 2016 |
| Determination of antidepressants in human urine extracted by magnetic multiwalled carbon nanotube poly (styrene‐co‐divinylbenzene) composites and separation by capillary … K Murtada, F de Andrés, A Ríos, M Zougagh Electrophoresis 39 (14), 1808-1815, 2018 | 32 | 2018 |
| The psychostimulant khat (Catha edulis) inhibits CYP2D6 enzyme activity in humans W Bedada, F de Andrés, E Engidawork, A Pohanka, O Beck, L Bertilsson, ... Journal of Clinical Psychopharmacology 35 (6), 694-699, 2015 | 32 | 2015 |
| Screening of non-polar heterocyclic amines in urine by microextraction in packed sorbent-fluorimetric detection and confirmation by capillary liquid chromatography F De Andrés, M Zougagh, G Castañeda, JL Sánchez-Rojas, A Ríos Talanta 83 (5), 1562-1567, 2011 | 32 | 2011 |
| Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans F Rodrigues‐Soares, EM Peñas‐Lledó, E Tarazona‐Santos, ... Clinical Pharmacology & Therapeutics 107 (1), 257-268, 2020 | 30 | 2020 |
| Multiplex Phenotyping for Systems Medicine: A One-Point Optimized Practical Sampling Strategy for Simultaneous Estimation of CYP1A2, CYP2C9, CYP2C19, and CYP2D6 Activities … F de Andrés, S Terán, M Bovera, H Farinas, E Terán, A LLerena Omics: a journal of integrative biology 20 (2), 88-96, 2016 | 30 | 2016 |
| Achiral liquid chromatography with circular dichroism detection for the determination of carnitine enantiomers in dietary supplements and pharmaceutical formulations F de Andrés, G Castañeda, Á Ríos Journal of pharmaceutical and biomedical analysis 51 (2), 478-483, 2010 | 30 | 2010 |
Adrián LLerena MD PhD Professor Cli...INUBE Biosanitary University Research Institute. University of Extremadura. CICAB Clinical ResearchVerified email at unex.es
